thebench.bio #1 Ecosystem for the Bio-Tech Industry

Research Daily Summary

Research Daily Summary: What Happened on November 14, 2026

Blood marker distinguishes advanced CTE in preliminary study

The findings point to a possible way to detect severe disease, but the marker is not validated for CTE diagnosis.

  • Updated
  • Read from 1 article, 1 publication

Today in brief

Washington University researchers found that blood levels of eMTBR-tau243 rose with CTE severity and separated advanced cases from controls with an AUC of 0.97.1 The preliminary study found lower accuracy for stage I CTE, and the marker alone cannot distinguish CTE from Alzheimer’s disease.1